Trial intelligence / Profile preview

Selincro in Alcohol Dependent Patients With Liver Impairment

NCT02197598Phase 4Completed

Sponsor
Lundbeck
Start
Sep 2014
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nalmefene in alcohol dependence, sponsored by Lundbeck. Started Sep 2014; status: completed.

02

Drugs

nalmefene
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT02197598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02197598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call